Holmium Yttrium-Aluminum-Garnet Laser Lithotripsy: An Effective Endoscopic Treatment for Bouveret's Syndrome.

Turk J Gastroenterol

Department of Gastroenterology, Çukurova University School of Medicine, Balcalı Hospital, Adana, Turkey.

Published: March 2024

Cite this article as: Güler HS, Üsküdar O. Holmium yttrium-aluminum-garnet laser lithotripsy: An effective endoscopic treatment for Bouveret's syndrome. Turk J Gastroenterol. 2024;35(3):262-263.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059983PMC
http://dx.doi.org/10.5152/tjg.2024.23552DOI Listing

Publication Analysis

Top Keywords

holmium yttrium-aluminum-garnet
8
yttrium-aluminum-garnet laser
8
laser lithotripsy
8
lithotripsy effective
8
effective endoscopic
8
endoscopic treatment
8
treatment bouveret's
8
bouveret's syndrome
8
syndrome cite
4
cite article
4

Similar Publications

Optimizing the Appropriate Mode of the Pulse-Modulated Holmium Laser in a Pop-Dusting Benchtop Model.

Urology

December 2024

Division of Urology, Department of Surgery, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand.

Objectives: To investigate the effectiveness of different holmium:yttrium-aluminum-garnet (Ho:YAG) laser modes for lithotripsy in the "dusting era" and identify the optimal laser mode for producing stone fragments measuring ≤0.5 mm.

Methods: We used plaster of Paris-made artificial stones crushed into 2-3 mm pieces, weighing 1 g in total.

View Article and Find Full Text PDF

We aim to evaluate stone-free rate (SFR) and complications after flexible ureteroscopy (F-URS) for kidney stones, using a flexible and navigable suction ureteral access sheath (FANS), comparing thulium fiber laser (TFL) and high-power holmium:yttrium-aluminum-garnet laser (HPHL). Data from adults who underwent F-URS in 15 centers were prospectively analyzed (August 2023-January 2024). Exclusion criteria were ureteral stones, concomitant bilateral procedures, and renal abnormalities.

View Article and Find Full Text PDF
Article Synopsis
  • - This clinical study compares the effectiveness and safety of two lasers, the holmium: yttrium-aluminum-garnet (HO:YAG) and the superpulse thulium fiber laser (SP TFL), in treating kidney stones via ureterorenoscopic lithotripsy.
  • - Patients will be randomly assigned to receive treatment with either laser, with outcomes measured for stone elimination and various surgical performance indicators 30 days post-operation.
  • - The study is registered under ChiCTR2300076893 and aims to provide insights on whether the newer SP TFL can serve as a better alternative to the established HO:YAG laser.
View Article and Find Full Text PDF

Background And Objective: Ureteral stones are currently treated with holmium:yttrium-aluminum-garnet (Ho:YAG) laser lithotripsy using rigid and flexible ureteroscopes. This study aims to evaluate the efficacy and safety of semirigid ureteroscopy combined with Ho:YAG laser lithotripsy for treating proximal ureteral stones in real-world studies.

Methods: The PubMed, Embase, and Web of Science databases were searched systematically to retrieve all relevant studies up to April 2024.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the safety of FURL (fiber-enabled ureteroscopic laser lithotripsy) using 365 μm fibers and Ho: YAG laser over a 16-week period, focusing on clinical outcomes and risks.
  • A total of 274 patients showed a high stone-free rate (SFR) linked to stone size and composition, with no severe complications observed post-procedure.
  • Urosepsis occurred in only 1.82% of patients, and critical infection-related lab values remained stable, indicating that kidney function was preserved throughout the follow-up period.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!